Cargando…
Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
We present the case of a 73-year-old male patient with a history of tobacco use who presented with a central nervous system mass that was confirmed to be a lung adenocarcinoma metastasis. High PD-L1 expression as well as negativity to other targetable drivers led to initiation of pembrolizumab monot...
Autores principales: | Cardona, Andrés F., Ruiz-Patiño, Alejandro, Zatarain-Barron, Zyanya Lucia, Ariza, Santiago, Ricaurte, Luisa, Rolfo, Christian, Arrieta, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983585/ https://www.ncbi.nlm.nih.gov/pubmed/33776733 http://dx.doi.org/10.1159/000514144 |
Ejemplares similares
-
Comprehensive review of fetal adenocarcinoma of the lung
por: Ricaurte, Luisa María, et al.
Publicado: (2018) -
Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab − Diagnostic and Therapeutic Challenge: A Case Report
por: Cardona, Andrés F., et al.
Publicado: (2020) -
Challenges and shifting paradigms in clinical trials in oncology: the case for immunological and targeted therapies
por: Sotelo-Rodríguez, Diana Carolina, et al.
Publicado: (2019) -
Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019) -
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review
por: Rodríguez, July, et al.
Publicado: (2021)